Reported positive results from the potentially registrational Phase 2 ZEPHYR trial of ML-007C-MA in schizophrenia, supporting advancement into a Phase 3 ZEPHYR-2 trial Continued advancement of ML-007C ...
G beyond the hype: how speed, latency, and edge will change, and what practical effects it will have compared to 5G in homes, ...
More than a decade ago, Dr. Matthew Hebb was treating patients with Parkinson's disease using deep brain stimulation by implanting tiny electrodes into the brain and delivering electrical signals to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results